Nxstage Medical Inc (NXTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2004 | |
| Sales | 442 |
| Cost of Goods | 906 |
| Gross Profit | -464 |
| Operating Expenses | 4,104 |
| Operating Income | -3,662 |
| Interest Expense | 3 |
| Other Income | 33 |
| Pre-tax Income | -3,632 |
| Net Income Continuous | -3,632 |
| Net Income | $-3,632 |
| EPS Basic Total Ops | -1.42 |
| EPS Basic Continuous Ops | -1.42 |
| EPS Diluted Total Ops | -1.42 |
| EPS Diluted Continuous Ops | -1.42 |
| EBITDA(a) | $-3,662 |